Abstract A006: Outcomes from borderline resectable pancreatic ductal adenocarcinoma treated with immune checkpoint inhibition are associated with distinct features of lymphoid aggregates and plasma cell abundance
Year: 2025
Type: conference-abstract
Source: Cancer Immunology Research
Institution: University of California, Los Angeles
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4407866441